Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)

Market Cap	7.75B
Revenue (ttm)	2.37B
Net Income (ttm)	247.22M
Shares Out	210.96M
EPS (ttm)	1.18
PE Ratio	31.16
Forward PE	31.06
Dividend	0.19 (0.51%)
Ex-Dividend Date	May 14, 2025

Volume	4,339,667
Average Volume	3,337,360
Open	36.92
Previous Close	36.75
Day's Range	36.75 - 38.68
52-Week Range	17.86 - 48.39
Beta	0.59
RSI	40.22
Earnings Date	Apr 30, 2025

About SHA:688131

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 3,576
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688131

Financial Performance

In 2024, SHA:688131's revenue was 2.27 billion, an increase of 20.75% compared to the previous year's 1.88 billion. Earnings were 201.59 million, an increase of 58.17%.